4//SEC Filing
IVAX CORP 4
Accession 0001181431-05-033592
CIK 0000772197operating
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 2:39 PM ET
Size
14.0 KB
Accession
0001181431-05-033592
Insider Transaction Report
Form 4
IVAX CORPIVX
CONDELLA FRANK JR
Pres. IVAX Pharm. Europe
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2005-06-06$9.48/sh−25,000$237,000→ 62,500 totalExercise: $9.48Exp: 2009-07-28→ Common Stock (25,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2005-06-06$8.79/sh−31,250$274,750→ 31,250 totalExercise: $8.79Exp: 2010-03-05→ Common Stock (31,250 underlying) - Exercise/Conversion
Common Stock, $.10 par value per share
2005-06-06$9.48/sh+25,000$237,000→ 25,000 total - Sale
Common Stock, $.10 par value per share
2005-06-06$19.63/sh−25,000$490,748→ 0 total - Exercise/Conversion
Common Stock, $.10 par value per share
2005-06-06$8.79/sh+31,250$274,750→ 31,250 total - Sale
Common Stock, $.10 par value per share
2005-06-06$19.63/sh−31,250$613,434→ 0 total
Footnotes (3)
- [F1]Exercise price and number of options have been adjusted to reflect a 5-for-4 stock split effective on August 24, 2004.
- [F2]Options became exercisable in 4 equal installments of 31,250 shares each, beginning July 29, 2003.
- [F3]Options became exercisable in 4 equal installments of 15,625 shares each, beginning March 6, 2004.
Documents
Issuer
IVAX CORP
CIK 0000772197
Entity typeoperating
Related Parties
1- filerCIK 0000772197
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 2:39 PM ET
- Size
- 14.0 KB